2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 9: Cardiovascular Disease in Patients With ESRD.

Slides:



Advertisements
Similar presentations
Cardiovascular Disease In CKD: Is It for Children
Advertisements

Cardiovascular Implantable Electronic Device Leads & Arteriovenous Hemodialysis Access Theodore F. Saad, MD Nephrology Associates, PA Christiana Care Health.
Chapter 7: Pediatric ESRD 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Chapter 4: Hospitalization 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Chapter 3: Clinical Indicators and Preventive Care 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Chapter 2: Healthy People A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Chapter 4: Cardiovascular Disease in Patients With CKD 2014 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Chapter 6: Medicare Expenditures for CKD 2014 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Chapter 2: Identification and Care of Patients With CKD 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
Vol 2 Figure 1.1 Trends in the number of incident cases of ESRD, in thousands, by modality, in the U.S. population, Data Source: Reference.
Stages of CKD – KDOQI 2002 Definitions
Chapter 5: Mortality 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Chapter 5: Acute Kidney Injury 2014 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Chapter 3: Morbidity & Mortality 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 8: Pediatric ESRD.
Chapter 8: Transition of Care in Chronic Kidney Disease 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 6: Mortality.
Chapter 4: Cardiovascular Disease in Patients With CKD 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Chapter 2: Identification and Care of Patients With CKD 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 7: Transplantation.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 3: Clinical Indicators and Preventive Care.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 11: Costs of ESRD.
Introduction 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
(lines; scale on left) in the U.S. population,
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 14: End-of-life Care for Patients with End-Stage Renal Disease:
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 10: Dialysis Providers.
Chapter 6: Medicare Expenditures for Persons with CKD 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 12: Part D Prescription Drug Coverage in Patients with ESRD.
Chapter 5: Acute Kidney Injury 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 5: Hospitalization.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 2: Healthy People 2020.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 4: Vascular Access.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Survival of patients with diabetes and multivessel.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Scope of Coronary Heart Disease in Patients With.
2016 Annual Data Report, Vol 2, ESRD, Ch 5
2016 Annual Data Report, Vol 2, ESRD, Introduction
2016 Annual Data Report, Vol 1, CKD, Ch 4
Figure 9.1 Causes of death in ESRD patients,
2016 Annual Data Report, Vol 2, ESRD, Ch 6
Figure 10.1 Dialysis unit counts, by unit affiliation, 2011–2014
First-year death rates by modality figure 8
Table 6.1 Prevalent Medicare fee-for-service patient counts and spending for beneficiaries aged 65 and older, by DM, CHF, and/or CKD, 2014 U.S. Medicare.
Patient populations by study group figure 10
Chapter 2: Identification and Care of Patients With CKD
Volume 2: End-Stage Renal Disease
Volume 2: End-Stage Renal Disease
2016 Annual Data Report, Vol 1, CKD, Ch 2
Chapter 8: Cardiovascular Disease in Patients with ESRD
Volume 2: End-Stage Renal Disease Chapter 4: Hospitalization
Volume 1: Chronic Kidney Disease
December 31st point prevalent counts by modality figure 3.1
2016 Annual Data Report, Vol 2, ESRD, Ch 4
Volume 1: Chronic Kidney Disease Chapter 5: Acute Kidney Injury
Hospital admissions per patient, by modality figure 5
Volume 1: Chronic Kidney Disease Chapter 3: Morbidity and Mortality
2016 Annual Data Report, Vol 2, ESRD, Ch 14
Volume 2: End-Stage Renal Disease Chapter 4: Hospitalization
Chapter 6: CKD among Children and Adolescents
2016 Annual Data Report, Vol 1, CKD, Ch 3
Brian Radbill, MD, Barbara Murphy, MD, Derek LeRoith, MD, PhD 
Chapter 4: Cardiovascular Disease in Patients with CKD
Chapter 3: Morbidity and Mortality
Volume 2: End-Stage Renal Disease
The US Renal Data System “Pie Chart of Death”
Chapter 2: Identification and Care of Patients with CKD
Chapter 8: Cardiovascular Disease in Patients with ESRD
In Reply to ‘The US Renal Data System “Pie Chart of Death”’
Recent Temporal Changes in Atherosclerotic Cardiovascular Diseases in Ontario: Clinical and Health Systems Impact  Jack V. Tu, MD, PhD, Anam M. Khan,
Figure 9.1.a Causes of death in ESRD patients,
Chapter 2: Identification and Care of Patients with CKD
Presentation transcript:

2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 9: Cardiovascular Disease in Patients With ESRD

Data Source: Reference Table H12. Abbreviations: AHD, atherosclerotic heart disease; AMI, acute myocardial infarction; CHF, congestive heart failure; CVA, cerebrovascular accident. Figure 9.1 Causes of death in ESRD patients, 2013 Vol 2, ESRD, Ch 92

Data Source: Special analyses, USRDS ESRD Database. Point prevalent hemodialysis, peritoneal dialysis, and transplant patients at all ages, with Medicare as primary payer on January 1, 2011, who are continuously enrolled in Medicare Parts A and B from July, 1, 2010 to December 31, 2010, ESRD service date is at least 90 days prior to January 1, 2011, and survived past Abbreviations: AFIB, atrial fibrillation; AMI, acute myocardial infarction; ASHD, atherosclerotic heart disease; CHF, congestive heart failure; CKD, chronic kidney disease; CVA/TIA, cerebrovascular accident/transient ischemic attack; CVD, cardiovascular disease; PAD, peripheral arterial disease; SCA/VA, sudden cardiac arrest and ventricular arrhythmias. Figure 9.2 Prevalence of cardiovascular diseases in ESRD patients, by treatment modality, 2013 Vol 2, ESRD, Ch 93

Data Source: Special analyses, USRDS ESRD Database. Point prevalent hemodialysis, peritoneal dialysis, and transplant patients at all ages, with Medicare as primary payer on January 1, 2011, who are continuously enrolled in Medicare Parts A and B from July, 1, 2010 to December 31, 2010, ESRD service date is at least 90 days prior to January 1, 2011, and survived past 2012.Abbreviations: AFIB, atrial fibrillation; AMI, acute myocardial infarction; ASHD, atherosclerotic heart disease; CHF, congestive heart failure; CKD, chronic kidney disease; CVA/TIA, cerebrovascular accident/transient ischemic attack; CVD, cardiovascular disease; PAD, peripheral arterial disease; SCA/VA, sudden cardiac arrest and ventricular arrhythmias. Figure 9.3 Prevalence of cardiovascular diseases in ESRD patients, by age, 2013 Vol 2, ESRD, Ch 94

Table 9.1 Prevalence of cardiovascular diseases & procedures in ESRD patients, by treatment modality, age, race, & sex, 2013 Vol 2, ESRD, Ch 95 # Patients % Patients Overall White Blk/Af Am OtherMaleFemale Cardiovascular Comorbidities a Atherosclerotic heart disease (ASHD) Hemodialysis 147, Peritoneal dialysis 11, Transplant 23, Acute myocardial infarction (AMI) Hemodialysis 147, Peritoneal dialysis 11, Transplant 23, Congestive heart failure (CHF) Hemodialysis 147, Peritoneal dialysis 11, Transplant 23, Cerebrovascular accident/transient ischemic attack (CVA/TIA) Hemodialysis 147, Peritoneal dialysis 11, Transplant 23, Peripheral artery disease (PAD) Hemodialysis 147, Peritoneal dialysis 11, Transplant 23, Atrial fibrillation (AFIB) Hemodialysis 147, Peritoneal dialysis 11, Transplant 23, (Continued on next slide)

Table 9.1 Prevalence of cardiovascular diseases & procedures in ESRD patients, by treatment modality, age, race, & sex, 2013 (Continued) Vol 2, ESRD, Ch 96 Data Source: Special analyses, USRDS ESRD Database. Point prevalent hemodialysis, peritoneal dialysis, and transplant patients at all ages, with Medicare as primary payer on January 1, 2011, who are continuously enrolled in Medicare Parts A and B from July, 1, 2010 to December 31, 2010, ESRD service date is at least 90 days prior to January 1, 2011, and survived past Abbreviations: AFIB, atrial fibrillation; AMI, acute myocardial infarction; ASHD, atherosclerotic heart disease; Af Am, African American; Blk, black; CABG, coronary artery bypass grafting; CHF, congestive heart failure; CKD, chronic kidney disease; CVA/TIA, cerebrovascular accident/transient ischemic attack; CVD, cardiovascular disease; ICD/CRT-D, implantable cardioverter defibrillators/cardiac resynchronization therapy with defibrillator devices; PAD, peripheral arterial disease; PCI, percutaneous coronary interventions; SCA/VA, sudden cardiac arrest and ventricular arrhythmias. a The denominators for all cardiovascular comorbidities are patients described above by modality. b The denominators for PCI and CABG are patients with ASHD by modality. The denominator for ICD/CRT-D is patient with CHF by modality. # Patients % Patients Overall White Blk/Af Am OtherMaleFemale Cardiac arrest and ventricular arrhythmias (SCA/VA) Hemodialysis 147, Peritoneal dialysis 11, Transplant 23, Cardiovascular Procedures b Revascularization – percutaneous coronary interventions (PCI) Hemodialysis60, Peritoneal dialysis3, Transplant5, Revascularization – coronary artery bypass graft (CABG) Hemodialysis60, Peritoneal dialysis3, Transplant5, Implantable cardioverter defibrillators & cardiac resynchronization therapy with defibrillator (ICD/CRT-D) Hemodialysis 54, Peritoneal dialysis 2, Transplant 4,

Data Source: Special analyses, USRDS ESRD Database. Point prevalent hemodialysis, peritoneal dialysis, and transplant patients with Medicare as primary payer on January 1, 2011, who are continuously enrolled in Medicare Parts A and B from July, 1, 2010 to December 31, 2010, and whose first ESRD service date is at least 90 days prior to January 1, 2011, and survived past Abbreviation: ASHD, atherosclerotic heart disease. Figure 9.4 Probability of survival of ESRD patients with or without a cardiovascular disease or undergoing a cardiovascular procedure, Vol 2, ESRD, Ch 97 (a)ASHD

Data Source: Special analyses, USRDS ESRD Database. Point prevalent hemodialysis, peritoneal dialysis, and transplant patients with Medicare as primary payer on January 1, 2011, who are continuously enrolled in Medicare Parts A and B from July, 1, 2010 to December 31, 2010, and whose first ESRD service date is at least 90 days prior to January 1, 2011, and survived past Abbreviation: AMI, acute myocardial infarction. Figure 9.4 Probability of survival of ESRD patients with or without a cardiovascular disease or undergoing a cardiovascular procedure, Vol 2, ESRD, Ch 98 (b) AMI

Data Source: Special analyses, USRDS ESRD Database. Point prevalent hemodialysis, peritoneal dialysis, and transplant patients with Medicare as primary payer on January 1, 2011, who are continuously enrolled in Medicare Parts A and B from July, 1, 2010 to December 31, 2010, and whose first ESRD service date is at least 90 days prior to January 1, 2011, and survived past Abbreviation: CHF, congestive heart failure. Figure 9.4 Probability of survival of ESRD patients with or without a cardiovascular disease or undergoing a cardiovascular procedure, Vol 2, ESRD, Ch 99 (c) CHF

Data Source: Special analyses, USRDS ESRD Database. Point prevalent hemodialysis, peritoneal dialysis, and transplant patients with Medicare as primary payer on January 1, 2011, who are continuously enrolled in Medicare Parts A and B from July, 1, 2010 to December 31, 2010, and whose first ESRD service date is at least 90 days prior to January 1, 2011, and survived past Abbreviations: CVA/TIA, cerebrovascular accident/transient ischemic attack. Figure 9.4 Probability of survival of ESRD patients with or without a cardiovascular disease or undergoing a cardiovascular procedure, Vol 2, ESRD, Ch 910 (d) CVA / TIA

Data Source: Special analyses, USRDS ESRD Database. Point prevalent hemodialysis, peritoneal dialysis, and transplant patients with Medicare as primary payer on January 1, 2011, who are continuously enrolled in Medicare Parts A and B from July, 1, 2010 to December 31, 2010, and whose first ESRD service date is at least 90 days prior to January 1, 2011, and survived past Abbreviation: PAD, peripheral arterial disease. Figure 9.4 Probability of survival of ESRD patients with or without a cardiovascular disease or undergoing a cardiovascular procedure, Vol 2, ESRD, Ch 911 (e) PAD

Data Source: Special analyses, USRDS ESRD Database. Point prevalent hemodialysis, peritoneal dialysis, and transplant patients with Medicare as primary payer on January 1, 2011, who are continuously enrolled in Medicare Parts A and B from July, 1, 2010 to December 31, 2010, and whose first ESRD service date is at least 90 days prior to January 1, 2011, and survived past Abbreviation: AFIB, atrial fibrillation. Figure 9.4 Probability of survival of ESRD patients with or without a cardiovascular disease or undergoing a cardiovascular procedure, Vol 2, ESRD, Ch 912 (f) AFIB

Data Source: Special analyses, USRDS ESRD Database. Point prevalent hemodialysis, peritoneal dialysis, and transplant patients with Medicare as primary payer on January 1, 2011, who are continuously enrolled in Medicare Parts A and B from July, 1, 2010 to December 31, 2010, and whose first ESRD service date is at least 90 days prior to January 1, 2011, and survived past Abbreviations: SCA/VA, sudden cardiac arrest and ventricular arrhythmias. Figure 9.4 Probability of survival of ESRD patients with or without a cardiovascular disease or undergoing a cardiovascular procedure, Vol 2, ESRD, Ch 913 (g) SCA / VA

Data Source: Special analyses, USRDS ESRD Database. Point prevalent hemodialysis, peritoneal dialysis, and transplant patients with Medicare as primary payer on January 1, 2011, who are continuously enrolled in Medicare Parts A and B from July, 1, 2010 to December 31, 2010, and whose first ESRD service date is at least 90 days prior to January 1, 2011, and survived past Abbreviation: PCI, percutaneous coronary interventions. Figure 9.4 Probability of survival of ESRD patients with or without a cardiovascular disease or undergoing a cardiovascular procedure, Vol 2, ESRD, Ch 914 (h) PCI

Data Source: Special analyses, USRDS ESRD Database. Point prevalent hemodialysis, peritoneal dialysis, and transplant patients with Medicare as primary payer on January 1, 2011, who are continuously enrolled in Medicare Parts A and B from July, 1, 2010 to December 31, 2010, and whose first ESRD service date is at least 90 days prior to January 1, 2011, and survived past Abbreviation: CABG, coronary artery bypass grafting. Figure 9.4 Probability of survival of ESRD patients with or without a cardiovascular disease or undergoing a cardiovascular procedure, Vol 2, ESRD, Ch 915 (i) CABG

Data Source: Special analyses, USRDS ESRD Database. Point prevalent hemodialysis, peritoneal dialysis, and transplant patients with Medicare as primary payer on January 1, 2011, who are continuously enrolled in Medicare Parts A and B from July, 1, 2010 to December 31, 2010, and whose first ESRD service date is at least 90 days prior to January 1, 2011, and survived past Abbreviation: ICD/CRT/D, implantable cardioverter defibrillators/cardiac resynchronization therapy with defibrillator devices. Figure 9.4 Probability of survival of ESRD patients with or without a cardiovascular disease or undergoing a cardiovascular procedure, Vol 2, ESRD, Ch 916 (j) ICD / CRT / D

Data Source: Special analyses, USRDS ESRD Database. Point prevalent hemodialysis and peritoneal dialysis patients at all ages, with Medicare as primary payer on January 1, 2011, who are continuously enrolled in Medicare Parts A and B from July, 1, 2010 to December 31, 2010, ESRD service date is at least 90 days prior to January 1, 2011, and survived past Abbreviations: HD, hemodialysis; PD, peritoneal dialysis. Table 9.2 Characteristics of patients with heart failure, by treatment modality, 2013 Vol 2, ESRD, Ch 917 Systolic +/- Diastolic heart failureDiastolic only heart failureHeart failure, unspecified HDPDHDPDHDPD N%N%N%N%N%N% Age , , , , , , , , , , Sex Male8, , , Female5, , , Race White7, , , Black/African American 5, , , Other , Diabetes No4, , , Yes10, , ,